Medical Regulatory Issues Headlines

  • FDA declines to approve Apricus' erectile dysfunction cream

    (Reuters) - Apricus Biosciences Inc said on Friday the U.S. Food and Drug Administration declined to approve Vitaros, a cream-based treatment for erectile dysfunction, in its present form.

    in.reuters.com
  • U.S. FDA looks to pave way for earlier-stage Alzheimer's drugs

    (Reuters) - U.S. regulators have proposed lowering the bar for clinical trial success for experimental Alzheimer's drugs to better align with the current emphasis on the need to treat people when they are in the earliest stages of the brain-wasting disease.

    in.reuters.com
  • U.S. healthcare spending to climb 5.3 percent in 2018

    WASHINGTON (Reuters) - United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs, a U.S. government health agency said on Wednesday, an upward trend it forecasts for the next decade.

    in.reuters.com
  • U.S. healthcare spending to climb 5.3 percent in 2018: agency

    WASHINGTON (Reuters) - United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs, a U.S. government health agency said on Wednesday, an upward trend it forecasts for the next decade.

    in.reuters.com
  • Drug copies ready to take next bite out of Roche's cancer sales

    LONDON (Reuters) - European oncologists will soon get their hands on cut-price copies of breast cancer drug Herceptin, turning the screws on maker Roche and giving another boost to a new breed of companies focused on so-called biosimilars.

    in.reuters.com
  • Trump administration proposes ways to lower some U.S. drug costs: WSJ

    WASHINGTON (Reuters) - The Trump administration is proposing ways to curb the cost of prescription drugs for seniors and other Americans, the Wall Street Journal reported on Friday, acting on repeated pledges by President Donald Trump to tackle rising prices.

    in.reuters.com
  • Trump administration proposes ways to lower some U.S. drug costs: WSJ

    WASHINGTON (Reuters) - The Trump administration is proposing ways to curb the cost of prescription drugs for seniors and other Americans, the Wall Street Journal reported on Friday, acting on repeated pledges by President Donald Trump to tackle rising prices.

    www.reuters.com
  • Bellicum's cancer drug trials on clinical hold, shares tumble

    (Reuters) - Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company's experimental cancer drug after three cases of brain disease linked to head trauma.

    in.reuters.com